Oasmia looking to license Vitamin A-derived drug delivery tech
Oasmia Pharmaceutical has announced clinical results for its XR17 nanotechnology it says validates the excipient as a potential drug delivery system.
Archives for April 11, 2016
European group responds to Indian proposal to replace gelatin in capsules
A European chemical industry group has reiterated that gelatin is safe after Indian regulators called for feedback on a plan to replace the excipient with cellulose in pharmaceutical capsules.
US 'foots the bill' for global biopharma innovation, says ITIF
The US ranks first in terms of how its domestic policies contribute to global biopharmaceutical innovation, according to a recent analysis.
Celgene to commercialize Juno CD19 program
Celgene has exercised its option to develop and commercialize therapeutic antibody candidates that target CD19 - a protein found on cancerous B cells - in a deal with Juno therapeutics.
Vaccines and biologics driving Charles River investments
Demand for biological products has driven recent investments in vaccine manufacturing and cell banking, says Charles River Laboratories.
Quotient invests in spray drying tech in response to demand
Quotient Clinical has expanded spray drying capacity at its facility in Nottingham, UK citing growing industry interest in solubility enhancement.